Results 101 to 110 of about 93,143 (184)

Case Report: Olaparib combined with temozolomide and atezolizumab in a case of <i>BRCA2</i>-mutated small-cell transformation of lung adenocarcinoma. [PDF]

Front Oncol
Liu M, Gao P, Liu F, Li D, Wang Y, Yu J.
europepmc   +1 more source

Evaluating temozolomide for pediatric adamantinomatous craniopharyngiomas using microspheroid-based drug screening. [PDF]

Childs Nerv Syst
Cavalheiro S, Pavon LF, de Farias CB, da Silva NS, Nascimento FB, Sibov TT, Rodrigues JB, Dastoli PA, Suzuki FS, Watanabe RA, Kim IHT, Lichtenfels M, da Silva CA, Cappellano A, da Costa MDS.   +14 more
europepmc   +1 more source

[Retracted] Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine‑γ‑lyase function. [PDF]

Oncol Rep
Chen L, Li X, Liu L, Yu B, Xue Y, Liu Y.
europepmc   +1 more source

Hypoxia Increases Connexin46 and Connexin43 Levels in KNS-42 Glioblastoma Cells. [PDF]

Int J Mol Sci
Minogue PJ, Beyer EC, Berthoud VM.
europepmc   +1 more source

Retraction Note: Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway. [PDF]

Cancer Chemother Pharmacol
Xu P, Wang H, Pan H, Chen J, Deng C.
europepmc   +1 more source

Bitter Taste Signalling via TAS2R43 Enhances Temozolomide Efficacy in Glioblastoma Cells. [PDF]

Int J Mol Sci
Costa AR, Duarte AC, Gonçalves I, Preissner R, Cascalheira JF, Marcelino H, Santos CRA.   +6 more
europepmc   +1 more source

Temozolomide in aggressive and metastatic pituitary tumors: a Brazilian multicenter real-world cohort study. [PDF]

Pituitary
de Magalhães IPA, de Macedo CRPB, Naves LA, Czepielewski MA, Rosa IN, de Santana LB, de Almeida TS, Padula M, Elias PCL, de Castro M, Kasuki L, Gadelha MR, Rech CGSL, Garmes HM, Boguszewski CL, Jallad RS, Nakaguma M, Fragoso MCBV, Machado MC, Glezer A, da Cunha Neto MBC, Feher O, Batista RL.   +22 more
europepmc   +1 more source

Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma. [PDF]

Discov Oncol
Urbonas V, Dulskas A.
europepmc   +1 more source

Targeted and systemic therapies for recurrent adult ependymomas: real-world outcomes from a single institution and concise literature review. [PDF]

Front Oncol
Maccari M, Bosio A, Caccese M, Padovan M, Guerriero A, Librizzi G, Pintacuda G, Bellu L, Fiorentino A, Volpin F, Ius T, Chioffi F, Denaro L, Lonardi S, Lombardi G.   +14 more
europepmc   +1 more source

Targeted therapy in melanoma [PDF]

, 2009
Tawbi,
core   +1 more source